Veterinary Clinical Reference
Look up any drug or condition.
Evergreen, evidence-based hubs on the drugs, conditions, and species you manage — continuously updated and cited at every claim.
Antibiotic-Associated Dysbiosis and Enterotoxemia in Guinea Pigs
A prevention-first drug-safety reference on antibiotic-associated dysbiosis and clostridial enterotoxemia in guinea pigs and other hindgut fermenters: which antibiotic classes are contraindicated, which are flora-sparing, the route nuances, and how to recognize and manage iatrogenic enterotoxemia.
Read →Acquired Dental Disease in Chinchillas: Diagnosis and Treatment
Acquired dental disease is a leading cause of morbidity in pet chinchillas, driven by inadequate dietary abrasion of their continuously growing (aradicular hypsodont) incisors and cheek teeth. This clinical reference reviews the anatomy and pathophysiology, the clinical signs, why diagnosis requires skull radiographs or CT plus an oral examination under general anesthesia, and evidence-based treatment: crown reduction with a dental burr, analgesia, assisted feeding, prokinetics, and correction of the diet to unlimited grass hay.
Read →Egg Binding and Dystocia in Pet Birds: A Veterinary Clinical Reference
Egg binding (failure to pass an egg within the normal interval) and dystocia (mechanical obstruction of oviposition) are common, life-threatening emergencies in small psittacines such as cockatiels, budgerigars, and lovebirds. This reference covers definitions, hypocalcemia and husbandry risk factors, radiographic diagnosis, and the evidence-based treatment ladder from stabilization and parenteral calcium through PGE2 gel, oxytocin, ovocentesis, and salpingohysterectomy.
Read →Avian Aspergillosis in Birds: Aspergillus fumigatus Pathogenesis, Diagnosis, and Antifungal Treatment
A clinical reference on avian aspergillosis for veterinarians: how Aspergillus fumigatus causes opportunistic respiratory and systemic disease in psittacines, raptors, waterfowl, and penguins; why presentation is insidious; how to combine endoscopy, imaging, hematology, and serology for diagnosis; and evidence-based antifungal dosing — including the reduced itraconazole dose required in African grey parrots and voriconazole's species-specific toxicity.
Read →Sileo (Dexmedetomidine Oromucosal Gel) for Canine Noise Aversion: Dosing, Efficacy, and Safety
Sileo (dexmedetomidine oromucosal gel) is the first and only FDA-approved treatment for canine noise aversion — an alpha-2 agonist absorbed transmucosally, dosed by weight as syringe "dots" and given shortly before or at the onset of an anticipated noise event. This hub covers label dosing, the pivotal RCT, adverse effects, contraindications, and where it sits against trazodone, clonidine, tasipimidine, and daily SSRIs.
Read →Clonidine for Dogs: Off-Label Alpha-2 Agonist for Noise Aversion, Storm Phobia, and Situational Anxiety
Clonidine is a human alpha-2 adrenergic agonist used off-label in dogs as a short-acting, event-based adjunct for situational fear and anxiety — noise aversion, storm phobia, separation-related distress, fear reactivity, and vet-visit anxiety — layered on a daily SSRI or TCA plus behavior modification rather than run as standalone monotherapy. This hub summarizes the off-label dosing (~0.01–0.05 mg/kg PO), the limited open-label efficacy evidence, adverse effects, contraindications and interactions, and where clonidine sits relative to the FDA-approved event drug dexmedetomidine oromucosal gel (Sileo), trazodone, and gabapentin.
Read →Clomipramine (Clomicalm) for Dogs and Cats: Behavioral Dosing, Efficacy, and Safety
Clomipramine is a tricyclic antidepressant FDA-approved (Clomicalm) as an adjunct to behavior modification for canine separation anxiety, and used off-label for feline urine marking and canine/feline compulsive disorders. This hub covers species-specific dosing, the registration and compulsive-disorder RCTs, adverse effects, MAOI/serotonergic interactions, and where it sits versus fluoxetine, trazodone, and buspirone.
Read →Buspirone for Cats: Urine Spraying, Anxiety, and Off-Label Use in Feline Behavioral Medicine
Buspirone is a non-sedating azapirone (5-HT1A partial agonist) used off-label in cats, best supported for urine spraying/marking in multi-cat households and for generalized, social, and fear-based anxiety. Onset is 1–4 weeks, so it is a maintenance adjunct — not a rescue for acute situational anxiety.
Read →Trazodone for Dogs: Situational Anxiety and Post-Op Confinement Dosing
A clinical reference for prescribing trazodone in dogs: SARI mechanism, off-label status, situational and post-operative confinement dosing, onset, adverse effects, and serotonin syndrome risk with concurrent SSRIs and MAOIs.
Read →Fluoxetine (Reconcile) for Canine Behavior Disorders
Clinical reference on fluoxetine (Reconcile/Prozac) for dogs: FDA-approved separation-anxiety indication, 1-2 mg/kg dosing, 4-6 week onset, adverse effects, and the MAOI/amitraz and serotonin-syndrome interactions every prescriber must screen for.
Read →Methylxanthine (Chocolate & Caffeine) Toxicosis in Dogs
ER reference for canine methylxanthine (chocolate/caffeine) toxicosis: theobromine/caffeine MOA and kinetics, mg/kg dose thresholds, chocolate-type ranking, decontamination, and symptomatic management of tachyarrhythmia, seizures, and hyperthermia.
Read →Lily Nephrotoxicosis in Cats: AKI Emergency Reference
Any true-lily (Lilium or Hemerocallis) exposure in a cat is a nephrotoxic emergency — pollen and vase water included. Clinician reference on the unidentified toxin, proximal tubular necrosis, the biphasic timeline, early glucosuria, aggressive IV fluid diuresis, and the ~18-hour therapeutic window.
Read →